BNP Paribas Exane Lowers Clorox (NYSE:CLX) Price Target to $101.00

Clorox (NYSE:CLX) had its price objective reduced by BNP Paribas Exane from $103.00 to $101.00 in a research note issued on Friday,MarketScreener reports. The firm presently has an “underperform” rating on the stock. BNP Paribas Exane’s price objective suggests a potential downside of 8.14% from the company’s previous close.

Several other research analysts have also issued reports on the stock. TD Cowen decreased their price target on shares of Clorox from $117.00 to $108.00 and set a “hold” rating for the company in a research note on Thursday, January 8th. Morgan Stanley decreased their target price on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. Cowen reissued a “hold” rating on shares of Clorox in a research report on Thursday, January 8th. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Finally, UBS Group lowered their price objective on Clorox from $119.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday. One research analyst has rated the stock with a Buy rating, fourteen have assigned a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and a consensus price target of $122.19.

Clorox Trading Down 1.2%

NYSE:CLX opened at $109.95 on Friday. The company has a fifty day moving average of $103.13 and a 200 day moving average of $115.26. Clorox has a 52 week low of $96.66 and a 52 week high of $164.22. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01. The firm has a market capitalization of $13.41 billion, a P/E ratio of 17.26, a P/E/G ratio of 0.54 and a beta of 0.58.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same period last year, the company earned $1.86 EPS. The business’s quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, research analysts predict that Clorox will post 7.15 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Pierre R. Breber purchased 4,000 shares of the company’s stock in a transaction dated Friday, November 21st. The shares were purchased at an average price of $104.13 per share, with a total value of $416,520.00. Following the acquisition, the director directly owned 13,000 shares in the company, valued at $1,353,690. The trade was a 44.44% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

A number of hedge funds have recently bought and sold shares of CLX. Center for Financial Planning Inc. purchased a new position in shares of Clorox in the third quarter worth approximately $25,000. Vermillion & White Wealth Management Group LLC purchased a new stake in shares of Clorox in the 3rd quarter worth $25,000. Total Investment Management Inc. bought a new position in Clorox in the 2nd quarter worth $25,000. American National Bank & Trust lifted its position in Clorox by 69.5% during the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after purchasing an additional 89 shares in the last quarter. Finally, True Wealth Design LLC grew its holdings in Clorox by 1,020.0% during the third quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after purchasing an additional 204 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.